Independent product guide to Dragons' Den · Every availability claim is checked
CATTLEytics productLeft without a deal

Dragons' Den Canada Season 20 · Episode 16

CATTLEytics

dairy-farm management software for herd tracking

Still sellingTech and Software

Dairy-farm software CATTLEytics carried a heavy valuation and met a wall of pushback. We cover the ask and the no-deal that followed.

The ask$1.2 mfor 10% of the business
Implied valuation$12Mask / equity
On-air resultNo deal
Still sellingFounder: Shari Van de Pol

The pitch

What walked into the Den

CATTLEytics, from Hamilton, Ontario, builds management software that helps dairy farms track their herds, founded by veterinarian Dr. Shari Van de Pol.

She pitched in season 20 with a high ask: $1.2 million for 10 percent, which valued the company at $12 million.

After the show

What happened next

There was no deal. Trade coverage in The Bullvine reports the Dragons hammered the valuation, called the pitch a pressure cooker and walked, with one telling Van de Pol she could bootstrap on the government funding already coming her way, a read corroborated by a Farmtario headline noting publicity but no investment.

The company kept climbing regardless. Its site in July 2026 described more than 500 farms served and over two million animals tracked, with a working customer portal and an award-finalist mention.

Our read

The Hub verdict

The $1.2 million for 10 percent ask is a $12 million valuation, and the Dragons' pushback was the whole story: trade coverage describes them hammering the multiple and walking, with one arguing the founder could bootstrap on incoming government funding. So this is a sourced no-deal. Post-show growth figures circulate, and they may well be accurate, but they were not independently confirmable here, so we tag them as company and press claims rather than facts, and keep the verified spine, no deal plus a live B2B service.

Valuation rejected, no deal; growth claims unconfirmed

Worth knowing: The no-deal outcome is well sourced. Reports of strong post-show growth were not something we could independently confirm, so we note them as company and press claims rather than verified figures.